Mangrove Partners’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Hold |
|
|||||
|
2025
Q1 | $1.66M | Hold |
|
|||||
|
2024
Q4 | $2.98M | Sell |
|
|||||
|
2024
Q3 | $5.61M | Hold |
|
|||||
|
2024
Q2 | $6.2M | Hold |
|
|||||
|
2024
Q1 | $6.5M | Buy |
|
|||||
|
2023
Q4 | $3.67M | Hold |
|
|||||
|
2023
Q3 | $3.18M | Hold |
|
|||||
|
2023
Q2 | $2.52M | Hold |
|
|||||
|
2023
Q1 | $3.65M | Sell |
|
|||||
|
2022
Q4 | $5.34M | Hold |
|
|||||
|
2022
Q3 | $4.14M | Buy |
|
|||||
|
2022
Q2 | $1.7M | Hold |
|
|||||
|
2022
Q1 | $3.52M | Buy |
|
|||||
|
2021
Q4 | $2.59M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.22M | Hold |
|
|||||
|
2020
Q2 | $1.88M | Sell |
|
|||||
|
2020
Q1 | $1.36M | Sell |
|
|||||
|
2019
Q4 | $1.97M | Hold |
|
|||||
|
2019
Q3 | $1.31M | Hold |
|
|||||
|
2019
Q2 | $2.11M | Buy |
|
|||||
|
2019
Q1 | $3.31M | Buy |
|
|||||
|
2018
Q4 | $3.65M | Hold |
|
|||||
|
2018
Q3 | $8.62M | Hold |
|
|||||
|
2018
Q2 | $7.55M | Buy |
|
|||||
|
2018
Q1 | $4.38M | Hold |
|
|||||
|
2017
Q4 | $2.71M | Buy |
|
|||||
|
2017
Q3 | $1.97M | Buy |
|